Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of LifeStance Health Group Inc (NASDAQ: LFST) was $5.35 for the day, down -1.11% from the previous closing price of $5.41. In other words, the price has decreased by -$1.11 from its previous closing price. On the day, 2.82 million shares were traded. LFST stock price reached its highest trading level at $5.41 during the session, while it also had its lowest trading level at $5.26.
Ratios:
Our analysis of LFST’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.01 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.33. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 1.48. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on July 25, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On May 27, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $8.50.
On April 08, 2025, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $9.KeyBanc Capital Markets initiated its Overweight rating on April 08, 2025, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 18 ’25 when Silversmith Capital Partners I bought 894,098 shares for $5.41 per share.
Silversmith Capital Partners I bought 2,471,741 shares of LFST for $13,372,119 on Aug 18 ’25. On Aug 18 ’25, another insider, Silversmith Capital Partners I, who serves as the Shareholder of the company, bought 226,518 shares for $5.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFST now has a Market Capitalization of 2080807552 and an Enterprise Value of 2388974848. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.58 while its Price-to-Book (P/B) ratio in mrq is 1.41. Its current Enterprise Value per Revenue stands at 1.815 whereas that against EBITDA is 40.563.
Stock Price History:
The Beta on a monthly basis for LFST is 1.16, which has changed by -0.074394464 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, LFST has reached a high of $8.61, while it has fallen to a 52-week low of $3.74. The 50-Day Moving Average of the stock is 13.58%, while the 200-Day Moving Average is calculated to be -17.54%.
Shares Statistics:
LFST traded an average of 2.50M shares per day over the past three months and 4252330 shares per day over the past ten days. A total of 389.08M shares are outstanding, with a floating share count of 143.66M. Insiders hold about 63.06% of the company’s shares, while institutions hold 37.86% stake in the company. Shares short for LFST as of 1753920000 were 7412301 with a Short Ratio of 2.96, compared to 1751241600 on 8670558. Therefore, it implies a Short% of Shares Outstanding of 7412301 and a Short% of Float of 8.59.
Earnings Estimates
The current assessment of LifeStance Health Group Inc (LFST) involves the perspectives of 1.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.04, with high estimates of $0.04 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.17 and $0.17 for the fiscal current year, implying an average EPS of $0.17. EPS for the following year is $0.2, with 1.0 analysts recommending between $0.2 and $0.2.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $357.8M to a low estimate of $354M. As of the current estimate, LifeStance Health Group Inc’s year-ago sales were $312.72MFor the next quarter, 7 analysts are estimating revenue of $379.12M. There is a high estimate of $384M for the next quarter, whereas the lowest estimate is $374.5M.
A total of 8 analysts have provided revenue estimates for LFST’s current fiscal year. The highest revenue estimate was $1.42B, while the lowest revenue estimate was $1.41B, resulting in an average revenue estimate of $1.41B. In the same quarter a year ago, actual revenue was $1.25BBased on 8 analysts’ estimates, the company’s revenue will be $1.62B in the next fiscal year. The high estimate is $1.64B and the low estimate is $1.58B.
